세계의 D 다이머 검사 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

The Global D-dimer Testing market is forecasted to grow at a noteworthy CAGR of 4.58% between 2025 and 2033. By 2033, market size is expected to surge to USD 3.67 Billion, a substantial rise from the USD 2.45 Billion recorded in 2024.

The D-dimer testing market is expanding significantly due to its critical role in diagnosing thrombotic disorders such as deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. Advances in immunoassay technologies, including point-of-care testing (POCT) and high-sensitivity assays, are enhancing diagnostic accuracy, speed, and accessibility. The integration of automated analyzers and digital reporting systems is streamlining laboratory workflows and improving result reliability. Growing awareness of coagulation disorders and the increasing prevalence of cardiovascular diseases are driving demand for D-dimer testing in clinical settings.

The COVID-19 pandemic has underscored the importance of D-dimer testing in assessing coagulopathy and guiding treatment decisions, further accelerating market growth. Innovations in multiplex testing platforms and biomarker panels are expanding diagnostic capabilities and clinical utility. Regulatory approvals and reimbursement policies are facilitating adoption across hospitals, diagnostic centers, and outpatient clinics. Additionally, the development of portable and user-friendly devices is enabling decentralized testing and rapid decision-making.

Collaborations among diagnostic companies, healthcare providers, and research institutions are fostering continuous innovation and clinical validation. As thrombotic diseases remain a significant health burden globally, the D-dimer testing market is positioned for robust growth, supporting timely diagnosis and improved patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the D-dimer Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Analyzers
• Reagents & Consumables

By Test Type

• Clinical Laboratory Tests
• Point-of-Care Tests

By Method

• Enzyme-linked Immunosorbent Assay (ELISA)
• Latex-enhanced Immunoturbidimetric Assays
• Fluorescence Immunoassays
• Others

By Application

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Disseminated Intravascular Coagulation (DIC)
• Others

By End Use

• Hospitals
• Academic & Research Institutes
• Diagnostic Centers
• List of Companies Profiled in the report
• Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens Healthcare, Abbott, Biomerieux, Werfen, Horiba Ltd., QuidelOrtho Corporation, Diazyme Laboratories, Biomedica Diagnostics, Sekisui Diagnostics.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. D DIMER TESTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Test Type
  • 3.7.3 Market Attractiveness Analysis By Method
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By End Use
  • 3.7.6 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL D DIMER TESTING MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Analyzers Historic and Forecast Sales By Regions
• 5.4. Reagents & Consumables Historic and Forecast Sales By Regions

6. GLOBAL D DIMER TESTING MARKET ANALYSIS BY TEST TYPE

• 6.1. Overview By Test Type
• 6.2. Historical and Forecast Data Analysis By Test Type
• 6.3. Clinical Laboratory Tests Historic and Forecast Sales By Regions
• 6.4. Point-of-Care Tests Historic and Forecast Sales By Regions

7. GLOBAL D DIMER TESTING MARKET ANALYSIS BY METHOD

• 7.1. Overview By Method
• 7.2. Historical and Forecast Data Analysis By Method
• 7.3. Enzyme-linked Immunosorbent Assay (ELISA) Historic and Forecast Sales By Regions
• 7.4. Latex-enhanced Immunoturbidimetric Assays Historic and Forecast Sales By Regions
• 7.5. Fluorescence Immunoassays Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL D DIMER TESTING MARKET ANALYSIS BY APPLICATION

• 8.1. Overview By Application
• 8.2. Historical and Forecast Data Analysis By Application
• 8.3. Deep Vein Thrombosis (DVT) Historic and Forecast Sales By Regions
• 8.4. Pulmonary Embolism (PE) Historic and Forecast Sales By Regions
• 8.5. Disseminated Intravascular Coagulation (DIC) Historic and Forecast Sales By Regions
• 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL D DIMER TESTING MARKET ANALYSIS BY END USE

• 9.1. Overview By End Use
• 9.2. Historical and Forecast Data Analysis By End Use
• 9.3. Hospitals Historic and Forecast Sales By Regions
• 9.4. Academic & Research Institutes Historic and Forecast Sales By Regions
• 9.5. Diagnostic Centers Historic and Forecast Sales By Regions

10. GLOBAL D DIMER TESTING MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2 North America By Segment Sales Analysis
  • 10.3.3 North America By Country Sales Analysis
  • 10.3.4 United States Sales Analysis
  • 10.3.5 Canada Sales Analysis
  • 10.3.6 Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2 Europe By Segment Sales Analysis
  • 10.4.3 Europe By Country Sales Analysis
  • 10.4.4 United Kingdom Sales Analysis
  • 10.4.5 France Sales Analysis
  • 10.4.6 Germany Sales Analysis
  • 10.4.7 Italy Sales Analysis
  • 10.4.8 Russia Sales Analysis
  • 10.4.9 Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2 Asia Pacific By Segment Sales Analysis
  • 10.5.3 Asia Pacific By Country Sales Analysis
  • 10.5.4 China Sales Analysis
  • 10.5.5 India Sales Analysis
  • 10.5.6 Japan Sales Analysis
  • 10.5.7 South Korea Sales Analysis
  • 10.5.8 Australia Sales Analysis
  • 10.5.9 South East Asia Sales Analysis
  • 10.5.10 Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2 Latin America By Segment Sales Analysis
  • 10.6.3 Latin America By Country Sales Analysis
  • 10.6.4 Brazil Sales Analysis
  • 10.6.5 Argentina Sales Analysis
  • 10.6.6 Peru Sales Analysis
  • 10.6.7 Chile Sales Analysis
  • 10.6.8 Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2 Middle East & Africa By Segment Sales Analysis
  • 10.7.3 Middle East & Africa By Country Sales Analysis
  • 10.7.4 Saudi Arabia Sales Analysis
  • 10.7.5 UAE Sales Analysis
  • 10.7.6 Israel Sales Analysis
  • 10.7.7 South Africa Sales Analysis
  • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE D DIMER TESTING COMPANIES

• 11.1. D Dimer Testing Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12. COMPANY PROFILES OF D DIMER TESTING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Thermo Fisher Scientific Inc.
  • 12.3.1 Company Overview
  • 12.3.2 Company Revenue
  • 12.3.3 Products
  • 12.3.4 Recent Developments
• 12.4. F. Hoffmann-La Roche Ltd
  • 12.4.1 Company Overview
  • 12.4.2 Company Revenue
  • 12.4.3 Products
  • 12.4.4 Recent Developments
• 12.5. Siemens Healthcare
  • 12.5.1 Company Overview
  • 12.5.2 Company Revenue
  • 12.5.3 Products
  • 12.5.4 Recent Developments
• 12.6. Abbott
  • 12.6.1 Company Overview
  • 12.6.2 Company Revenue
  • 12.6.3 Products
  • 12.6.4 Recent Developments
• 12.7. BiomeRieux
  • 12.7.1 Company Overview
  • 12.7.2 Company Revenue
  • 12.7.3 Products
  • 12.7.4 Recent Developments
• 12.8. Werfen
  • 12.8.1 Company Overview
  • 12.8.2 Company Revenue
  • 12.8.3 Products
  • 12.8.4 Recent Developments
• 12.9. Horiba Ltd.
  • 12.9.1 Company Overview
  • 12.9.2 Company Revenue
  • 12.9.3 Products
  • 12.9.4 Recent Developments
• 12.10. QuidelOrtho Corporation
  • 12.10.1 Company Overview
  • 12.10.2 Company Revenue
  • 12.10.3 Products
  • 12.10.4 Recent Developments
• 12.11. Diazyme Laboratories
  • 12.11.1 Company Overview
  • 12.11.2 Company Revenue
  • 12.11.3 Products
  • 12.11.4 Recent Developments
• 12.12. Biomedica Diagnostics
  • 12.12.1 Company Overview
  • 12.12.2 Company Revenue
  • 12.12.3 Products
  • 12.12.4 Recent Developments
• 12.13. Sekisui Diagnostics
  • 12.13.1 Company Overview
  • 12.13.2 Company Revenue
  • 12.13.3 Products
  • 12.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies